Olfat Mahdy | Diseases | Best Innovation Award

Prof. Dr. Olfat Mahdy | Diseases | Best Innovation Award

Parasitology Department at Faculty of veterinary Medicine, Cairo University, Egypt

Dr. Olfat Anter Mahdy Ahmed Auob is a renowned Professor of Parasitology at the Faculty of Veterinary Medicine, Cairo University. With decades of academic, research, and leadership experience, she has significantly advanced the fields of helminthology, protozoology, and fish parasitic diseases. Her contributions have shaped veterinary parasitology education and public health policies across Egypt and the wider Middle East. She has led pioneering research projects in zoonotic parasites, fish health, and nanotechnology-based diagnostics. Through active mentorship and scientific leadership, Dr. Olfat has trained numerous professionals and researchers. Her work continues to have lasting impact on veterinary science, disease control, and ecosystem health.

Professional Profiles

Β Google Scholar | Scopus Profile | ORCID Profile

Education

Dr. Olfat holds all her academic degrees in veterinary parasitology from Cairo University. Her early training focused on parasite identification and disease transmission in birds and aquatic species. She pursued advanced studies that incorporated morphological and biological analysis of helminths and protozoa, laying the foundation for her later specialization in zoonotic diseases and environmental parasitology. Throughout her academic path, she has maintained a strong integration of traditional microscopy with modern diagnostics, enabling her to bridge classical techniques and current innovations in parasitic disease research.

Experience

Dr. Olfat has served in multiple academic ranks at Cairo University, currently holding a professorship in parasitology. She teaches undergraduate and postgraduate courses in helminthology, protozoology, and entomology. In addition to classroom teaching, she leads laboratory training, supervises theses, and mentors researchers. She has provided technical training to veterinarians and health professionals from neighboring countries and conducted numerous national workshops. She is also active in academic promotion and assessment committees in various countries. Her practical work includes collaborations on fish parasitic diseases, zoonoses, and environmental parasitology with government and research institutions.

Award and Honor

Dr. Olfat has been honored repeatedly for her contributions to research and education. She has received multiple awards for internationally published work in peer-reviewed journals. Her research in fish parasitology, zoonotic infections, and diagnostic innovation has been widely recognized by academic institutions and scientific committees. She has been invited to serve on faculty promotion panels and advisory boards in several countries and is often consulted for national research evaluation. Her career is marked by consistent acknowledgment of her scientific excellence, leadership, and dedication to parasitology and public health.

Research Focus

Her research interests span helminthic and protozoal diseases affecting domestic and wild animals, particularly those with public health relevance. A major emphasis of her work lies in the diagnosis and control of parasitic infections in fish, using advanced tools such as scanning electron microscopy and molecular markers. She has contributed to the development of nanotechnology applications in parasite management, particularly in aquaculture. Her projects address parasite biodiversity, zoonotic risks, and the ecological impacts of environmental pollutants on aquatic life. Her interdisciplinary research strengthens sustainable veterinary practices and food safety initiatives.

Research Skill

Dr. Olfat is skilled in morphological and molecular parasite identification, scanning electron microscopy, and the integration of nanotechnology in disease control. She designs and conducts laboratory experiments, manages multi-disciplinary research teams, and delivers expert training to students and professionals. Her teaching capabilities include course design, academic advising, and evaluation. She plays a key role in national academic promotion and research quality assurance. Her technical and communication skills have made her a leader in diagnostic parasitology, curriculum development, and cross-border knowledge exchange in veterinary science.

Publication Top Notes

Title: An Innovative Approach to Control Fish-Borne Zoonotic Metacercarial Infections in Aquaculture by Utilizing Nanoparticles
Published: Scientific Reports
Year: 2024
Citations: 4

Title: Evaluation of Praziquantel Effectiveness in Treating Nile Tilapia Clinostomid Infections and Its Relationships to Fish Health and Water Quality
Published: BMC Veterinary Research
Year: 2024
Citations: 5

Title: Innovative Molecular and Immunological Approaches of Heterophyiasis Infecting Some Egyptian Marketed Fishes
Published: BMC Veterinary Research
Year: 2024
Citations: 9

Conclusion

Naghmeh Satarzadeh | Biotechnology | Best Researcher Award

Assist. Prof. Dr. Naghmeh Satarzadeh | Biotechnology | Best Researcher Award

Assistant Professor at Kerman University of Medical Sciences, Iran

Dr. Naghmeh Satarzadeh is a dynamic Iranian researcher and academic, currently pursuing her Ph.D. in Pharmaceutical Biotechnology at Kerman University of Medical Sciences. With a solid foundation in microbiology and biotechnology, her expertise spans across nanomedicine, phage therapy, and microbial applications in drug development. Over the years, she has made significant contributions to the field of biosynthesized nanoparticles and antibacterial agents, with multiple peer-reviewed publications. Naghmeh is also an active reviewer for prestigious international journals, showcasing her commitment to advancing scientific knowledge. Her passion for innovation is reflected in her award-winning research ideas and her involvement in commercializing health technologies. In addition to her research, she has taught several undergraduate and Pharm.D. courses, further underlining her dedication to education and mentorship. Known for her academic excellence and multidisciplinary approach, she continues to push the boundaries of science through collaboration, creativity, and resilience.

Professional ProfilesπŸ“–

ORCIDΒ 

Education πŸŽ“

Dr. Naghmeh Satarzadeh’s academic journey began with a B.Sc. in Microbiology from Islamic Azad University (2005–2009), where she developed a deep interest in microbial sciences. She pursued her M.Sc. in Microbial Biotechnology at Payam Noor University (2011–2013), gaining hands-on experience in applied microbiology and molecular techniques. In 2017, she embarked on her Ph.D. in Pharmaceutical Biotechnology at the Faculty of Pharmacy, Kerman University of Medical Sciences, where she has since distinguished herself through pioneering research in nanoparticle biosynthesis and phage technology. Her educational path is marked by a consistent pursuit of innovation, critical thinking, and academic excellence. Her achievements include top GPA among Ph.D. entrants and multiple recognitions for her research ideas and outputs. Dr. Satarzadeh’s formal training is complemented by her deep understanding of both fundamental biology and advanced biotechnological techniques, positioning her as a versatile scholar capable of translating science into impactful medical solutions.

Work ExperienceπŸ’Ό

Dr. Naghmeh Satarzadeh has cultivated a rich blend of academic, research, and teaching experience throughout her career. As a lecturer, she has taught various undergraduate and Pharm.D. courses, including Genetics Laboratory, Molecular Biology, and Biotechnology, shaping future generations of scientists. Her research experience includes extensive laboratory work in DNA extraction, nanoparticle synthesis, bacteriophage biology, and cytotoxicity analysis. She has led and co-authored over 20 scientific publications, many of which explore innovative biomedical applications of biosynthesized nanoparticles and phages. Dr. Satarzadeh is also a trusted peer reviewer for several leading journals such as BMC Microbiology, BioNanoScience, and Virology Journal, which speaks to her credibility in the scientific community. She has actively contributed to health technology innovation centers, bridging the gap between research and practical application. With a career grounded in interdisciplinary science and translational research, Dr. Satarzadeh continues to build impactful experiences that serve both academia and society.

Awards and Honors πŸ†

Dr. Naghmeh Satarzadeh has been recognized multiple times for her outstanding academic performance and innovative contributions to biotechnology. In 2018, her research idea was selected for presentation at the First Pharmaceutical Technology Commercialization Festival in Dubai. She earned first place in both the 2020 Idea Talk Speech Competition and the 2021 national call for extremophile research proposals. Her scientific excellence was further acknowledged in 2022 and 2023 when she registered novel bacterial strains (Bacillus tequilensis ASFS1 and Brevundimonas vesicularis strain sataricum) in GenBank. In 2023, she achieved the highest GPA among Ph.D. entrants in her field and was named Outstanding Talent. She was also recognized by Kerman University’s Health Technology Incubator and awarded First Researcher by both the National Student Research Committee and the Faculty of Pharmacy. These accolades reflect her dedication to scientific innovation, academic leadership, and her ability to transform complex research into recognized contributions.

SkillsπŸ’‘

Dr. Satarzadeh is highly skilled in a wide range of laboratory techniques essential for modern biomedical research. Her molecular biology toolkit includes DNA extraction, PCR, multiplex PCR, PCR-RFLP, and SDS-PAGE. She has hands-on experience with electrophoresis, bacteriophage cultivation, and DNA sequencing. She is proficient in nanoparticle synthesis using both bacterial and herbal sources and in analyzing their bioactivity through cytotoxicity and antioxidant assays. Her expertise extends to microbial testing, HPLC, TLC, and FTIR spectroscopy. In cell biology, she works adeptly with cell culture systems and MTT assays. She is proficient in data analysis using SPSS and is adept with scientific software such as Endnote, Chromas, CodonCode, CLC Genomics, IRPal, and ChemDraw. Additionally, her skillset includes primer design and gene analysis using Gene Runner. These diverse capabilities enable her to conduct interdisciplinary research at the intersection of microbiology, nanotechnology, and pharmacology.

Research Focus πŸ”¬

Dr. Naghmeh Satarzadeh’s research centers around microbial biotechnology, with a specialized focus on biosynthesized nanoparticles, phage therapy, and microbial agents for medical applications. Her work bridges microbiology and nanomedicine, leveraging bacteria and bacteriophages to synthesize metal nanoparticles with therapeutic properties, including anticancer, antibacterial, and antioxidant effects. She is particularly interested in extremophiles and their unique biochemical pathways for novel compound production. Her recent studies delve into the biomedical potential of selenium and arsenic nanostructures, immunoglobulin Y conjugation, and green synthesis using medicinal plants like Mentha pulegium. Dr. Satarzadeh also explores epigenetic interactions with nanomaterials and the role of microbial agents in combatting drug-resistant infections and viral diseases such as COVID-19. Her research stands out for its interdisciplinarity, combining molecular biology, pharmacology, and material science to develop sustainable, effective health solutions. She is passionate about translating lab-based discoveries into clinical and industrial applications for a healthier future.

Conclusionβœ…

Dr. Naghmeh Satarzadeh is a highly competitive and deserving candidate for the Best Researcher Award. Her multidisciplinary research contributions, peer recognition, and academic accomplishments collectively present a compelling case. While a few areas such as international engagement and commercialization can be enhanced, her overall profile aligns very well with the criteria typically valued for such an award. She exemplifies innovation, productivity, and academic service.

Publications Top NotesπŸ“š

COVID-19 (Coronavirus disease 2019): a new coronavirus disease

πŸ“‘ Citations: 104

πŸ“… Year: 2020

Mentha pulegium as a source of green synthesis of nanoparticles…

πŸ“‘ Citations: 38

πŸ“… Year: 2023

An insight into biofabrication of selenium nanostructures and their biomedical application

πŸ“‘ Citations: 25

πŸ“… Year: 2023

Medicinal and Therapeutic Properties of Ephedra

πŸ“‘ Citations: 25

πŸ“… Year: 2022

Facile microwave-assisted biosynthesis of arsenic nanoparticles…

πŸ“‘ Citations: 21

πŸ“… Year: 2023

Antimicrobial activity of Ephedra pachyclada methanol extract…

πŸ“‘ Citations: 18

πŸ“… Year: 2016

Association between VKORC1 gene polymorphism and warfarin dose…

πŸ“‘ Citations: 14

πŸ“… Year: 2020

A review on immunoglobulin Y (IgY) conjugated with metal nanoparticles…

πŸ“‘ Citations: 13

πŸ“… Year: 2023

Phage therapy as a glimmer of hope in surgical site infections

πŸ“‘ Citations: 12

πŸ“… Year: 2024

Synthesized arsenic nanoparticles and their biomedical potential: a review

πŸ“‘ Citations: 10

πŸ“… Year: 2024

The impact of COVID-19 on liver injury in various age groups

πŸ“‘ Citations: 10

πŸ“… Year: 2023

The use of phages for the biosynthesis of metal nanoparticles…

πŸ“‘ Citations: 9

πŸ“… Year: 2024

Purification and anticancer activity of iron oxide nanoparticles by Bacillus tequilensis

πŸ“‘ Citations: 5

πŸ“… Year: 2024

The use of Ephedra herbs in the treatment of COVID-19

πŸ“‘ Citations: 5

πŸ“… Year: 2023

The spread of carbapenemase genes in K. pneumoniae in Iran: A review

πŸ“‘ Citations: 5

πŸ“… Year: 2021

Mutuality of epigenetics and nanoparticles: two sides of a coin

πŸ“‘ Citations: 4

πŸ“… Year: 2024

Relationship between early childhood caries and lactose in breast milk

πŸ“‘ Citations: 3

πŸ“… Year: 2022

Biological applications of nanoparticles synthesized via Olea europaea

πŸ“‘ Citations: 2

πŸ“… Year: 2024

[Cu(dimethylbpy)β‚‚Cl]PF₆ complex as an antibacterial agent

πŸ“‘ Citations: 1

πŸ“… Year: 2024

Hepatitis B and C infection in Jirof blood donors (2011–2016)

πŸ“‘ Citations: 1

πŸ“… Year: 2022